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Abstract: Paepalanthus spp., Eriocaulaceae, are native plants from Brazil 
known as "sempre-vivas" (everlasting flowers). In this work, we evaluated the 
potential anti-mycobacterial activity of two methoxylated flavonoids (flavonoid 
7-methylquercetagetin and 7-methylquercetagetin-4′-O-β-D-glucopyranoside) 
isolated and identified from P. latipes and the naphthopyranone fractions from P. 
bromeliodes ethanolic extracts. The MIC value of 500 μg/mL was verified for all 
compounds tested against M. tuberculosis H37Rv. For M. avium, the MIC value 
ranged from 1000-2000 μg/mL excepting to naphthopyranone fractions with MIC 
of 500 μg/mL. This is the first report of activity determination of Paepalanthus spp. 
flavonoids activity against Mycobacterium tuberculosis and M. avium.
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Introduction
 Tuberculosis still remains an important public 
health problem worldwide, accounting for eight 
million new cases per year (WHO, 2007). The agent of 
tuberculosis, Mycobacterium tuberculosis kills nearly 
three million people a year throughout the world. Despite 
improvements in chemotherapy, tuberculosis is severely 
affected by the development of multi-resistant strains 
to drugs that are commonly used to treat the disease 
(WHO, 2007). The treatment of infections caused by 
other opportunistic environmental Mycobacterium 
species as M. avium is difficult, due theirs intrinsic 
resistance to a wide range of medications (Nuermberger 
& Grosset, 2004). Most Mycobacterium species are 
resistant to isonicotinic acid hydrazide (isoniazid), one 
of the most used therapeutic agents for the treatment of 
tuberculosis (Chung et al., 2006; Zhang et al., 1992). 
These challenges have motivated the research of novel 
antimycobacterial agents to reduce the global burden 
of tuberculosis and have been discussed in the current 
biomedical literature (Wilkinson et al., 2007; Pavan et 
al., 2009; Higuchi et al., 2011, Ma et al., 2010).
 Natural products and/or their semi-synthetic 
derivatives can lead to novel antimycobacterial drugs 
and may have important role in the chemotherapy of 
tuberculosis. The literature reports the antimycobacterial 
activity of many classes of natural products such as 
alkanes, phenolics, acetogenic quinones, fl avonoids, and 
triterpenes (Pauli et al., 2005; Copp & Pearce, 2007).
 Eriocaulaceae is a pantropical, predominantly 
herbaceous monocotyledonous family, comprising 
around 1400 species in ten genera (Giulietti et al., 
2012). Plants of this family are known as “everlasting 
flower” ("sempre-vivas" in Portuguese, since they 
maintain their appearance and color after drying) and 
they can be found in “Campos Rupestres” vegetation in 
Brazil. These plants are exported to Europe, Japan and 
North America as an ornamental flower, representing 
an important source of income to the population of 
Minas Gerais State, Brazil (Giulietti et al., 2012).
 Taxonomic studies to delimit the genus, 
about which there is still some confusion, and the 
biological investigation into the isolated molecules of 
Eriocaulaceae, are of great importance, because several 
molecules possess antioxidant actions (Santos et al., 
2003), citotoxic and mutagenic activities (Moreira 
et al., 2002), macrophage activation (Moreira et al., 
2001). 
 This study aimed to evaluate the 
antimycobacterial activity against M. tuberculosis 
and M. avium of the two flavonoids (6-hydroxy-
7-methoxyquercetin (1) and 6-hydroxy-7-
methoxyquercetin-4`-O-β-D-glucopyranoside (2) 
from 96% crude ethanolic extract from P. latipes 
and the naphthopyranone fractions obtained from P. 
bromeliodes.
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Material and Methods
Plant material
 Paepaplanthus spp., Eriocaulaceae, were 
collected at Serra do Cipó, Minas Gerais State, Brazil, 
and authenticated by Prof. Paulo Takeo Sano. Voucher 
specimens of Paepalanthus latipes Silveira (SPF/CFSC 
13846) and P. bromelioides Silveira (SPF/CFSC 13856), 
were deposited at the Herbarium of the Institute of 
Biosciences, University of São Paulo, Brazil.
Preparation and fractionation of extracts and isolation 
of compounds
 The aerial parts of the P. latipes and P. 
bromeliodes were dried in an oven with air circulation, 
at 60 °C for seven days, and then powdered. The dry 
powders were macerated (528 g of P. latipes and 500 g 
of P. bromeliodes) for one week, at room temperature, 
with 96% ethanol. The macerates were filtered and 
evaporated at 60 °C under reduced pressure, resulting 
in 11 g of the dry extract of P. latipes and 8 g of P. 
bromelioides. The extracts were fractioned by gel 
permeation column Sephadex LH-20 (Pharmacia) and 
96% methanol as eluent, resulting in 110 fractions 
for P. latipes and 150 fractions for P. bromelioides. 
Naphthiopyranone fractions were identified by thin layer 
chromatography (mobile phase: CHCl3:MeOH:H2O, 
43:37:20 v/v/v, developer: NP/PEG and viewing 
under UV) (Vilegas et al., 1990). The compounds 
6-hydroxy-7-methoxyquercetin (1) and 6-hydroxy-7-
methoxyquercetin-4`-O-β-D-glucopyranoside (2) were 
identified by spectroscopic methods (IR, UV, ES-MS, 
NMR 1D and 2D) (Nehme, 1997).
Mycobacterial strains 
 Mycobacterium tuberculosis H37Rv ATCC 
27294 and Mycobacterium avium ATCC 15769 were 
obtained from the American Type Culture Collection 
(Manassas, VA, USA). The mycobacteria were cultured 
in Middlebrook 7H9 supplemented with 10% OADC and 
additional 0.05% Tween 80 (to avoid clumps), at 37 °C for 
7-10 or 3-5 days, respectively for M. tuberculosis and M. 
avium. 
Antimycobacterial activity-Determination of in vitro 
Minimum Inhibitory Concentration (MIC)
 The antimycobacterial activity was assessed 
using the Alamar BlueTM (MABA) method (Collins & 
Franzblau, 1997). Microplates of 96 wells were used. 
The wells were filled with different concentrations of 
extracts and compounds in dimethyl sulfoxide (DMSO), 
which varied from 4000 to 250 μg/mL. Isoniazid 
(Difco, Detroit, MI, USA) was the antimycobacterial 
drug standard, at concentrations of 0.015-0.50 μg/
mL. The tests were performed in triplicate. According 
to this technique, the MIC of a compound is the 
concentration that inhibit 90% of the growth of M. 
tuberculosis H37Rv, using Alamar BlueTM (resazurin) 
as a vital fluorescent dye. The bacterial suspensions 
were prepared at a concentration equivalent to the 
turbidity standard of McFarland n° 1 and diluted in the 
ratio 1:25 in Middlebrook 7H9 Broth. The inoculum 
was supplemented with 10% OADC. Cultures were 
incubated for seven days at 37 oC and then added Alamar 
Blue for reading. A negative control was performed 
without mycobacteria to confirm the absence of reaction 
of the tested compounds with the resazurin. The dye 
fluorescence (indicative of bacterial growth) was 
measured in a microfluorimeter (Tecan SPECTRAfluor 
Plus microplate reader), with excitation at 530 nm and 
emission at 590 nm (Collins & Franzblau, 1997). 
Results
 The fractionation and rechromatographed of 
crude ethanolic extracts in silica gel CC resulted in 
isolation of two methoxylated flavonoids previously 
isolated from P. latipes (Villegas et al., 1999) and 
naphthopyranone fraction from P. bromeliodes. 
 The NMR studies showed that both flavonoids 
have a methoxy group at position 7, and a hydroxyl 
group at position 6 which does not occur in quercetin, 
luteolin and 3-methylquercetin. Besides, this the 
flavonoid 7-methylquercetagetin (1) presents two 
free hydroxyl at C3’ and C4', analogously to the three 
flavonoids mentioned. The 7-methylquercetagetin 
(1) was identified in fractions 90-102 (9.0 mg) and 
7-methylquercetagetin-4´-O-β-D-glucopyranoside (2) 
was identified in fractions 69-78 (10.0 mg), as well 
as in the crude ethanolic extract from P. latipes. The 
results obtained from the ES-MS (70 V, positive mode) 
confirmed the identification of the flavonoids 1 and 2, 
by comparison with the results of Nehme (1997), which 
also support our NMR data. The naphthopyranones 
(paepalantine-9-O-β-D-glycopyranosyl-(1-6)-β-
D-glycopyranoside (3), paepalantine-9-O-β-D-
allopyranosyl-(1-6)-β-D-glycopyranoside (4)) were 
identified in fractions 25-35 (6.5 mg) of the P. 
bromeliodes crude ethanolic extract by thin layer 
chromatography (Rf 0.40 and 0.45) and the results were 
confirmed using benchmarks according Vilegas et al 
(1990).
 The antimycobacterial activities of the extracts, 
fractions and flavonoids from Paepalanthus spp. and P. 
latipes against M. tuberculosis and M. avium, using the 
Alamar Blue assay (MABA), are showed in Table 1. The 
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ethanol extracts and isolated compounds tested against 
M. tuberculosis H37Rv showed low activity, with MIC 
value of 500 μg/mL. M. avium was even more resistant 
to the ethanol extracts and compounds (MIC ranging 
on 1000-2000 μg/mL), excepting to naphthopyranone 
fraction, whose MIC was 500 μg/mL.
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Table 1. Antimycobacterial activity of Paepalanthus spp. 
crude extracts, methoxylated flavonoids and naphthopyranone 
fraction.
Samples M. tuberculosis MIC (μg/mL)
M. avium 
MIC (μg/mL)
P. latipes 96% ethanolic extract 500 1000
P. bromelioides 96% ethanolic 
extract
500 2000
7- methylquercetagetin 500 1000
7-methylquercetagetin-4´-O-β-D-
glucopyranoside
500 1000
naphthopyranone fraction 500 500
Discussion
 Many natural products, including essential oils 
and phenolic compounds have been extensively tested for 
antibacterial activity (Friedman et al., 2002; 2003; 2004; 
2006). 
 In this study, the ethanol extract and methoxylated 
flavonoids (flavonoid 7-methylquercetagetin and 
7-methylquercetagetin-4´-O-β-D-glucopyranoside) 
from P. latipes, and naphthopyranone fractions isolated 
from P. bromeliodes ethanolic extract, tested against 
M. tuberculosis and M. avium, exhibited no significant 
antimycobacterial activity, despite their characteristic of 
polyphenolic compounds. The MIC values ranged from 
500 μg/mL against M. tuberculosis to 1000-2000 μg/mL 
to M. avium, except for naphthopyranone, that presented 
the same 500 μg/mL MIC against both bacteria. 
 Tosun et al. (2004) considered inactive the plant 
extracts that could not prevent growth of M. tuberculosis 
up to concentration of 200 μg/mL. According to Gu et al. 
(2004), a MIC≤128 mg/mL defines a substance as active 
against M. tuberculosis (Gu et al., 2004). For Cantrell et 
al. (2001), isolated compounds that exhibit a MIC of 64 
μg/mL or lower are considered promising (Cantrell et al., 
2001). 
 Thus, the high MIC value of 500 μg/mL, 
disqualifies the isolated flavonoids compounds or purified 
naphthopyranone fractions as promising candidates against 
M. tuberculosis and M. avium. The antimycobacterial 
activity of flavonoids has already been reported by many 
authors. Lin et al. (2002) described the antimycobacterial 
activity of 142 synthetic chalcones, flavonoids (including 
some methoxyflavones) and chalconeslike compounds. 
Murillo et al. (2003) analyzed fourteen flavonoids 
from Derris indica, including rotenoids and prenylated 
isoflavones (Murillo et al., 2003). The antimycobacterial 
methoxyflavones from Kaempferia parviflora was also 
report by Gu et al. (2004). However, according to Castellar 
et al (2011), in all researches, no correlation on structure-
activity of flavonoids against mycobacteria could be drawn. 
In the opinion of Silva et al. (2009), high lipophilicity of a 
substance is an important feature for its antimycobacterial 
activity.
 Due to the fact that the cell wall of mycobacteria 
contain high amount of lipids, such as mycolic acid, 
lipophilic substances are likely to penetrate more 
easily into the cell (Palomino et al., 2002). It has been 
demonstrated for a series of terpenes that the activity 
improves with the lipophilicity of a given substance, 
when compared to their more polar analogues (Cantrell 
et al., 2001). Pavan et al. (2009), from 37 plant extracts 
analyzed, found sixteen with promising activity, 
twelve of which were chloroform extracts and only 
four methanol extracts. The chloroform as extractor 
agent, could extracts more apolar compounds and the 
lipophilic nature of those compounds allows them to 
more easily penetrate the mycobacterial lipid rich cell 
wall. This probably favors their antimycobacterial 
activity.
 In previous reports, we have described the 
isolation and structure determination of paepalantine, 
a naphthopyran-1-one isolated from the chloroform 
extracts of the capitulae of Paepalanthus bromelioides, 
as well as from Paepalanthus vellozioides, with potent 
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antibiotic effect against S. aureus, S. epidermidis, 
Enterococcus faecalis and Escherichia coli (Coelho et 
al., 2000; Kitagawa et al., 2003; Devienne et al., 2005) 
and also antiviral activities (Cotterill et al., 2003). 
 In another study, we verified that ethanol 
extracts of P. bromeliodes and P. latipes were able to 
induce innate immune response through the production 
of high levels of H2O2 by mouse peritoneal macrophages 
(Moreira et al., 2001). Since M. tuberculosis can 
survive inside macrophages, their activation is essential 
for tuberculosis control. Thus, it is possible that the 
antimicrobial activity of the tested products, poorly in 
vitro, may be higher in vivo depending on macrophage 
activation.
Conclusion
 This is the first report of antimycobacterial 
activity of Paepalanthus spp. flavonoids. The results 
showed that the ethanol extracts, methoxylated 
flavonoids and naphthopyranone fractions exhibited 
no significant activity against M. tuberculosis and 
M. avium. Further, biological studies are needed to 
verify whether the antituberculosis activity in vivo is 
more intense, since the alcoholic extracts of the plant 
species studied were shown to be capable of producing 
macrophage activation. 
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